Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 657.25 INR
Change Today -15.65 / -2.33%
Volume 78.5K
As of 7:05 AM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

aarti drugs ltd (ARTD) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/8/15 - 874.90
52 Week Low
04/29/14 - 175.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for AARTI DRUGS LTD (ARTD)

Related News

No related news articles were found.

aarti drugs ltd (ARTD) Related Businessweek News

No Related Businessweek News Found

aarti drugs ltd (ARTD) Details

Aarti Drugs Limited is engaged in pharmaceuticals business in India and internationally. The company offers active pharmaceutical ingredients in various therapeutic categories, including anti inflammatory, cardioprotectant, antidiarrhoeals/antiprotozoles, antifungals, antiarthritis/osteoporosis, antihistamine, antibiotic, antidiabetic, alzheimer’s treatment, antihypertensive, antiBPH, sedative, vitamins, traquilizar, and antipsychotic. It also provides steroids, such as hydrocortisone sodium succinate sterile and hydrocortisone acetate; pharmaceutical intermediate products comprising valsartan, capecitabine, celecoxib, raloxifene, ketoconazole, and ziprasidone; and specialty chemical products, such as benzene sulphonamide, benzene sulphonic acid, benzene sulphonic acid methyl ester, benzene sulphonyl chloride, methyl nicotinate, N-methyl methane sulphonamide, ortho para toluene sulphonamide, ortho/para toluene sulphonic acid methyl ester, para chloro benzene sulphonamide, para chloro benzene sulphonyl chloride, para toluene sulphonamide, para toluene sulphonic acid methyl ester, and para toluene sulphonyl chloride. In addition, the company’s products under development comprises Telmisartan for the treatment of cardiovascular diseases; Topiramate for anticonvulsant; Aripiprazole for the treatment of antipsychotic; Acamprosate for alcoholism treatment; Hydralazine HCl and Labetalol for the treatment of antihypertensive; Propafenone HCl for antiarrhythmic treatment; and Ticonazole for use as an antifungal. It also exports its products to 97 countries, as well as offers contract manufacturing services. Aarti Drugs Limited was founded in 1984 and is based in Mumbai, India.

Founded in 1984

aarti drugs ltd (ARTD) Top Compensated Officers

Chairman, Chief Executive Officer, Managing D...
Total Annual Compensation: 5.8M
Joint Managing Director, Executive Director, ...
Total Annual Compensation: 5.0M
Managing Director, Whole-Time Director, Membe...
Total Annual Compensation: 4.9M
Whole-Time Director, Member of Share Transfer...
Total Annual Compensation: 5.0M
Whole-Time Director
Total Annual Compensation: 484.1K
Compensation as of Fiscal Year 2014.

aarti drugs ltd (ARTD) Key Developments

Aarti Drugs Limited, Board Meeting, Mar 26, 2015

Aarti Drugs Limited, Board Meeting, Mar 26, 2015. Agenda: To consider and approve the allotment of 12,108,550 equity shares as bonus issue in the proportion of 1 new equity share for every 1 existing fully paid equity shares as approved by the shareholders through postal ballot on March 13, 2015.

Aarti Drugs Limited Proposes to Amend Articles of Association and Memorandum of Association

Aarti Drugs Limited proposed to adopt new Articles of Association of the company containing regulations in conformity with The Companies Act, 2013 and alter the capital clause of the Memorandum of Association by way of postal ballot.

Aarti Drugs Limited Announces Board Appointments

Aarti Drugs Limited announced that the board of directors at the meeting held on January 30, 2015 approved the appointment of CA Navin C. Shah and CA Priti P. Savla as independent directors up to March 31, 2019.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARTD:IN 657.25 INR -15.65

ARTD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ARTD.
View Industry Companies

Industry Analysis


Industry Average

Valuation ARTD Industry Range
Price/Earnings 20.1x
Price/Sales 1.5x
Price/Book 5.8x
Price/Cash Flow 14.6x
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AARTI DRUGS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at